Cell death sensitization of leukemia cells by opioid receptor activation
Tóm tắt
Từ khóa
Tài liệu tham khảo
Poplack, 2011, Management strategies in acute lymphoblastic leukemia, Oncology (Williston Park), 25, 328
Kantarjian, 2010, Adult acute lymphoblastic leukemia: concepts and strategies, Cancer, 116, 1165, 10.1002/cncr.24862
Stahnke, 2011, Early relapse in all is identified by time to leukemia in NOD/SCID mice and is characterized by a gene signature involving survival pathways, Cancer Cell, 19, 206, 10.1016/j.ccr.2010.11.014
Hoelzer, 2011, Modern therapy of acute lymphoblastic leukemia, J Clin Oncol, 29, 532, 10.1200/JCO.2010.30.1382
Sabova, 2005, Anti-apoptotic proteins-targets for chemosensitization of tumor cells and cancer treatment, Neoplasma, 52, 441
Debatin, 1996, Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells, Nat Med, 2, 574, 10.1038/nm0596-574
Nunez, 2009, Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009, Cell Death Differ, 16, 3, 10.1038/cdd.2008.150
Fulda, 2009, Therapeutic opportunities for counteracting apoptosis resistance in childhood leukaemia, Br J Haematol, 145, 441, 10.1111/j.1365-2141.2009.07603.x
Joseph, 2011, TAp73alpha protects small cell lung carcinoma cells from caspase-2 induced mitochondrial mediated apoptotic cell death, Oncotarget, 2, 1145, 10.18632/oncotarget.391
Ahsan, 2011, Role of Bcl-2 family proteins and caspases in the regulation of apoptosis, Mol Cell Biochem, 351, 41, 10.1007/s11010-010-0709-x
Naderi, 2009, Activation of cAMP signaling inhibits DNA damage-induced apoptosis in BCP-ALL cells through abrogation of p53 accumulation, Blood, 114, 608, 10.1182/blood-2009-02-204883
Hayat, 2010, Inhibitory role of cAMP on doxorubicin-induced apoptosis in pre-B ALL cells through dephosphorylation of p53 serine residues, Apoptosis, 15, 196, 10.1007/s10495-009-0417-8
Devi, 1998, Molecular mechanisms of opioid receptor signal transduction, Br J Anaesth, 81, 12, 10.1093/bja/81.1.12
Loh, 2000, Molecular mechanisms and regulation of opioid receptor signaling, Annu Rev Pharmacol Toxicol, 40, 389, 10.1146/annurev.pharmtox.40.1.389
Pasternak, 1997, G proteins and opioid receptor-mediated signalling, Cell Signal, 9, 237, 10.1016/S0898-6568(96)00174-X
Aroonsakool, 2012, cAMP and Epac in the regulation of tissue fibrosis, Br J Pharmacol, 166, 447, 10.1111/j.1476-5381.2012.01847.x
Dale, 2008, Clinical pharmacology of methadone for pain, Acta Anaesthesiol Scand, 52, 879, 10.1111/j.1399-6576.2008.01597.x
Minna, 1990, Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines, Proc Natl Acad Sci U S A, 87, 3294, 10.1073/pnas.87.9.3294
Narendran, 2011, Induction of apoptosis in pediatric acute lymphoblastic leukemia (ALL) cells by the therapeutic opioid methadone and effective synergy with Bcl-2 inhibition, Leuk Res, 35, 1649, 10.1016/j.leukres.2011.06.035
Geisslinger, 2004, Opioids as modulators of cell death and survival--unraveling mechanisms and revealing new indications, Pharmacol Rev, 56, 351, 10.1124/pr.56.3.2
Miltner, 2008, Methadone, commonly used as maintenance medication for outpatient treatment of opioid dependence, kills leukemia cells and overcomes chemoresistance, Cancer Res, 68, 6059, 10.1158/0008-5472.CAN-08-1227
Minna, 1992, Nonconventional opioid binding sites mediate growth inhibitory effects of methadone on human lung cancer cells, Proc Natl Acad Sci U S A, 89, 1169, 10.1073/pnas.89.4.1169
Minna, 1994, Opioids induce while nicotine suppresses apoptosis in human lung cancer cells, Cell Growth Differ, 5, 1033
Henze, 2000, Childhood all blasts retain phenotypic and genotypic characteristics upon long-term serial passage in NOD/SCID mice, Pediatr Hematol Oncol, 17, 635, 10.1080/08880010050211349
Debatin, 1999, Chemotherapeutic drugs sensitize pre-B ALL cells for CD95- and cytotoxic T-lymphocyte-mediated apoptosis, Leukemia, 13, 400, 10.1038/sj.leu.2401327
Houin, 1999, The roles of P-glycoprotein and intracellular metabolism in the intestinal absorption of methadone: in vitro studies using the rat everted intestinal sac, Fundam Clin Pharmacol, 13, 494, 10.1111/j.1472-8206.1999.tb00009.x
Riordan, 1993, Synthetic and natural opiates interact with P-glycoprotein in multidrug-resistant cells, J Biol Chem, 268, 16059, 10.1016/S0021-9258(18)82357-2
Eap, 2007, In vitro P-glycoprotein-mediated transport of (R)-, (S)-, (R,S)-methadone, LAAM and their main metabolites, Pharmacology, 80, 304, 10.1159/000107104
Erickson, 2008, Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells, J Pharmacol Exp Ther, 324, 95, 10.1124/jpet.107.127704
Loh, 1985, Effect of pertussis toxin treatment on the down-regulation of opiate receptors in neuroblastoma X glioma NG108-15 hybrid cells, J Biol Chem, 260, 14818, 10.1016/S0021-9258(17)38645-3
McCubrey, 2012, Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment, Oncotarget, 3, 371, 10.18632/oncotarget.477
Pardee, 2010, The pursuit of oncotargets through understanding defective cell regulation, Oncotarget, 1, 544, 10.18632/oncotarget.189
Debatin, 2004, A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cells, Cell Death Differ, 11, 73, 10.1038/sj.cdd.4401431
Hoellenriegel, 2011, Phosphoinositide 3'-kinase delta: turning off BCR signaling in Chronic Lymphocytic Leukemia, Oncotarget, 2, 737, 10.18632/oncotarget.341
Platanias, 2011, AMPK in BCR-ABL expressing leukemias. Regulatory effects and therapeutic implications, Oncotarget, 2, 1322, 10.18632/oncotarget.413
van Beusechem, 2012, Targeting JNK-interacting-protein-1 (JIP1) sensitises osteosarcoma to doxorubicin, Oncotarget, 3, 1169, 10.18632/oncotarget.600
Gudkov, 2011, Proteotoxic stress targeted therapy (PSTT): induction of protein misfolding enhances the antitumor effect of the proteasome inhibitor bortezomib, Oncotarget, 2, 209, 10.18632/oncotarget.246
Mohammad, 2011, Network modeling of MDM2 inhibitor-oxaliplatin combination reveals biological synergy in wt-p53 solid tumors, Oncotarget, 2, 378, 10.18632/oncotarget.269
Martelli, 2012, A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia, Oncotarget, 3, 1615, 10.18632/oncotarget.762
Indolfi, 2005, Prognostic role of bcl-xL and p53 in childhood acute lymphoblastic leukemia (ALL), Cancer Biol Ther, 4, 32
Di Tullio, 2003, Determination of the in vivo effects of prednisone on Bcl-2 family protein expression in childhood acute lymphoblastic leukemia, Int J Oncol, 22, 123
Henze, 2010, XIAP expression is post-transcriptionally upregulated in childhood ALL and is associated with glucocorticoid response in T-cell ALL, Pediatr Blood Cancer, 55, 260, 10.1002/pbc.22541
Dalla-Favera, 2003, Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling, J Clin Invest, 111, 529, 10.1172/JCI200316624
Oudejans, 2005, Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas, Blood, 105, 2916, 10.1182/blood-2004-07-2716
Lankelma, 1995, Multidrug resistance proteins and other drug transport-related resistance to natural product agents, Curr Opin Oncol, 7, 532, 10.1097/00001622-199511000-00011
Izquierdo, 2003, Expression of multidrug resistance proteins P-glycoprotein, multidrug resistance protein 1, breast cancer resistance protein and lung resistance related protein in locally advanced bladder cancer treated with neoadjuvant chemotherapy: biological and clinical implications, J Urol, 170, 1383
Clarke, 2003, ATP binding cassette transporters and drug resistance in breast cancer, Endocr Relat Cancer, 10, 43
von Zastrow, 1999, Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction, Neuron, 23, 737, 10.1016/S0896-6273(01)80032-5
Karin, 1994, Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors, Curr Opin Cell Biol, 6, 415, 10.1016/0955-0674(94)90035-3
Rivard, 2001, cAMP protection of pancreatic cancer cells against apoptosis induced by ERK inhibition, Biochem Biophys Res Commun, 285, 207, 10.1006/bbrc.2001.5147
Aller, 1998, cAMP increasing agents attenuate the generation of apoptosis by etoposide in promonocytic leukemia cells, J Cell Sci, 111, 637
Kulik, 2007, Epinephrine protects cancer cells from apoptosis via activation of cAMP-dependent protein kinase and BAD phosphorylation, J Biol Chem, 282, 14094, 10.1074/jbc.M611370200
McDaniel, 2004, cAMP Dose-dependently prevents palmitate-induced apoptosis by both protein kinase A- and cAMP-guanine nucleotide exchange factor-dependent pathways in beta-cells, J Biol Chem, 279, 8938, 10.1074/jbc.M310330200
Green, 2003, An extranuclear locus of cAMP-dependent protein kinase action is necessary and sufficient for promotion of spiral ganglion neuronal survival by cAMP, J Neurosci, 23, 777, 10.1523/JNEUROSCI.23-03-00777.2003
Anwer, 2002, cAMP inhibits bile acid-induced apoptosis by blocking caspase activation and cytochrome c release, Am J Physiol Gastrointest Liver Physiol, 283, G727, 10.1152/ajpgi.00410.2001
Anwer, 1998, Cyclic adenosine monophosphate-mediated protection against bile acid-induced apoptosis in cultured rat hepatocytes, Hepatology, 27, 1324, 10.1002/hep.510270519
Hayat, 2010, Elevation of cyclic AMP causes an imbalance between NF-kappaB and p53 in NALM-6 cells treated by doxorubicin, FEBS Lett, 584, 3492, 10.1016/j.febslet.2010.07.009
Seeber, 2005, Pharmacokinetics (PK) of a liposomal encapsulated fraction containing doxorubicin and of doxorubicin released from the liposomal capsule after intravenous infusion of Caelyx/Doxil, Int J Clin Pharmacol Ther, 43, 588, 10.5414/CPP43588
Strumberg, 2006, Results of a Phase I trial of sorafenib (BAY 43-9006) in combination with doxorubicin in patients with refractory solid tumors, Ann Oncol, 17, 866, 10.1093/annonc/mdl017
Wedge, 2010, Guidelines for the welfare and use of animals in cancer research, Br J Cancer, 102, 1555, 10.1038/sj.bjc.6605642
McKean, 1997, Delta-opioid receptors expressed by Jurkat T cells enhance IL-2 secretion by increasing AP-1 complexes and activity of the NF-AT/AP-1-binding promoter element, J Immunol, 159, 5431, 10.4049/jimmunol.159.11.5431
Fiorilli, 1994, Detection and characterization of apoptotic peripheral blood lymphocytes in human immunodeficiency virus infection and cancer chemotherapy by a novel flow immunocytometric method, Blood, 83, 1268, 10.1182/blood.V83.5.1268.1268
Riccardi, 1991, A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry, J Immunol Meth, 139, 271, 10.1016/0022-1759(91)90198-O
Reske, 2007, Breaking chemoresistance and radioresistance with [213Bi]anti-CD45 antibodies in leukemia cells, Cancer Res, 67, 1950, 10.1158/0008-5472.CAN-06-3569
Friesen, 2013, Targeted alpha-therapy using [Bi-213]anti-CD20 as novel treatment option for radio- and chemoresistant non-Hodgkin lymphoma cells, Oncotarget, 4, 218, 10.18632/oncotarget.817
Debatin, 2003, Natural killer resistance of a drug-resistant leukemia cell line, mediated by up-regulation of HLA class I expression, Haematologica, 88, 509